Psychemedics Corporation

Psychemedics Corporation is a pioneer in the drug testing industry, offering the world’s leading hair drug test for detecting drugs of abuse. Established in 1986, Psychemedics (NASDAQ: PMD) has maintained its position as an industry innovator for over 30 years. The company's patented drug tests, utilizing hair samples, are trusted by numerous Fortune 500 companies, major police departments, and schools across the United States, with the aim of creating safer workplaces and campuses. Employing leading scientists in the field of drug detection science, Psychemedics sets itself apart by identifying more drug users for companies than any other hair testing laboratory globally. All Psychemedics drug screens are FDA 510k approved, including tests for emerging threats such as fentanyl and benzodiazepines. The company's commitment to advancing the science of hair testing for drugs of abuse underlines its dedication to ensuring safer environments through superior science and superior results. With its focus on analytics and biotechnology, Psychemedics Corporation continues to be at the forefront of the industry. For more information, interested parties can visit the company's website at www.psychemedics.com.